Worth reading
39Recurring
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
22500
¥ per stock acquisition rightWording
Definitive
How definitive the wording is.Details of issuance or disposal
Determination of the issue price of stock compensation-type stock options (stock acquisition rights) for directors
Who receives how much
30,100 common shares (301 stock acquisition rights)
4 directors of the Company, 301 rights (breakdown by recipient: 非開示)
The lower thin line represents the existing number of shares to which these shares will be added.
¥22,500 per right
Total issue value
¥6,772,500 (¥22,500 × 301 rights)
Amount of funds to be raised
No monetary payment is required. Estimated net proceeds: not applicable
Terms of the stock acquisition rights
Exercise price
¥1 per share. Whether there are adjustment provisions and the adjustment floor: Not disclosed
Exercise period
22 July 2026 to 21 July 2041
Number of Stock Acquisition Rights
Total number issued: 301 rights; balance unexercised: Not disclosed
Categories and Number of Persons Covered
4 directors of the Company, 301 rights
Basis for determining the amount to be paid
Director compensation equivalent to the accounting fair value on the allotment date
| Item | Details |
|---|---|
| Type of issuance or disposal | Determination of the issue price of stock compensation-type stock options (stock acquisition rights) for directors |
| Number of shares to be issued or disposed of | 30,100 common shares (301 stock acquisition rights) |
| Issue price and disposal price | ¥22,500 per right |
| Total issue value | ¥6,772,500 (¥22,500 × 301 rights) |
| Amount of funds to be raised | No monetary payment is required. Estimated net proceeds: not applicable |
| Intended allottee | 4 directors of the Company, 301 rights (breakdown by recipient: Not disclosed) |
| Basis for determining the amount to be paid | Director compensation equivalent to the accounting fair value on the allotment date |
| Exercise price | ¥1 per share. Whether there are adjustment provisions and the adjustment floor: Not disclosed |
| Exercise period | 22 July 2026 to 21 July 2041 |
| Number of Stock Acquisition Rights | Total number issued: 301 rights; balance unexercised: Not disclosed |
| Categories and Number of Persons Covered | 4 directors of the Company, 301 rights |
Items this document does not state (17)
Estimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The rights will be issued as director compensation equivalent to their accounting fair value on the allotment date, so no cash payment is required in exchange for the stock acquisition rights.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.